Weekly Recap | Moderna -3.11%, Friday reversal erases weekWeekly Review·Oct 17, 2026 at 07:39 AMMRNA-7.82%MRNY-5.06%
Weekly Recap | Illumina -5.62%, consensus target below spotWeekly Review·Oct 17, 2026 at 07:22 AMILMN-2.01%
Weekly Recap | Regeneron Pharma +5.92%, consensus target above spotWeekly Review·Oct 17, 2026 at 08:05 AMREGN-0.70%
Weekly Recap | Vertex Pharma -2.03%, pulled back after midweek rallyWeekly Review·Oct 17, 2026 at 08:25 AMVRTX-1.77%
Weekly Recap | Natera -1.81%, Signatera lands on TIME listWeekly Review·Oct 17, 2026 at 07:47 AMNTRA-2.80%
Weekly Recap | Revolution Medicines -6.22%, consensus target above spotWeekly Review·Oct 17, 2026 at 08:00 AMRVMD-5.97%
Weekly Recap | Amgen +4.25%, defensive bid amid tech pullbackWeekly Review·Oct 17, 2026 at 06:31 AMAMGN-0.35%
Weekly Recap | Gilead Sciences +3.32%, closing in on record highsWeekly Review·Oct 17, 2026 at 07:14 AMGILD-0.75%
Weekly Recap | Biogen +3.07%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 06:39 AMBIIB-1.15%
Weekly Recap | IBB.US -2.18%, big pharma draws inflowsWeekly Review·Oct 17, 2026 at 04:33 AMIBB-2.61%
Weekly Recap | Natera -2.35%, closing in on record highsWeekly Review·Oct 10, 2026 at 07:16 AMNTRA-2.80%
Weekly Recap | Argenx -10.25%, Sjögren's trial discontinuedWeekly Review·Oct 10, 2026 at 06:05 AMARGX-3.21%
Weekly Recap | IBB.US this week, a mixed tape for biotechWeekly Review·Oct 10, 2026 at 04:24 AMIBB-2.61%BIB-5.41%
Weekly Recap | IBB.US -2.14%, partnerships and a downgrade split the tapeWeekly Review·Oct 3, 2026 at 04:30 AMIBB-2.61%
Weekly Recap | IBB.US +2.55%, large-cap data flow lifts sectorWeekly Review·Sep 26, 2026 at 04:25 AMIBB-2.61%
